Ticker

Key Highlights Positive six-month results from the Company's First-in-Human ("FIH") study support advancement to Group Two clinical surgeries

Calgary, Alberta – TheNewswire - July 7, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a private placement (the “ Offering ”) of up to 5,000,000 units of the Corporation (“ Units ”) at a price of $0.40 per Unit for gross proceeds of up to $2,000,000. There will be no minimum subscription level for the Offering.…

Key Highlights $1.4 million of debenture principal converted to common shares of Ocumetics

Key Highlights Precision molds received for manufacturing of new optimized accommodating intraocular lenses

Calgary, Alberta – TheNewswire - April 29, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a private placement (the “ Offering ”) of up to 2,800,000 units of the Corporation (“ Units ”) at a price of $0.55 per Unit for gross proceeds of up to $1,540,000. There will be no minimum subscription level for the Offering.…